2.68
price down icon1.11%   -0.03
after-market Dopo l'orario di chiusura: 2.68
loading

Perché le azioni Erasca Inc (ERAS) sono in ribasso?

Abbiamo notato un calo di 10.21% nelle azioni di Erasca Inc (ERAS) durante la sessione di negoziazione di 2024-09-23. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-28:

Shares of Erasca Inc (ERAS) dropped by 11.38% from $2.24 to $1.99 in the trading on Tuesday, November 28, 2023. The reason why ERAS is down today is due to the company's program updates, particularly regarding its SEACRAFT-2 Phase 3 trial for Naporafenib Plus Trametinib and its THUNDERBBOLT-1 Phase 1 trial for ERAS-801. Investors may have been concerned about the trial details, including the patient population and comparator arm in SEACRAFT-2, as well as the need for additional data for ERAS-801. Additionally, the company's decision to deprioritize certain programs and focus on more promising initiatives could have contributed to the stock's decline.

$24.33
price up icon 0.87%
$358.53
price up icon 0.23%
$218.42
price up icon 2.77%
$65.75
price up icon 2.85%
$118.22
price up icon 0.49%
$536.11
price up icon 2.20%
Capitalizzazione:     |  Volume (24 ore):